Lessons from viral vectors, CAR-T, & RNA

Phage production has its quirks, but it’s not the only field trying to reliably manufacture a new biological entity. This week I share learnings from Australia’s annual bioprocessing conference about challenges other fields are facing, and what we might borrow as we prepare phages for the clinic.